Form 4 for TYRA Tyra Biosciences, Inc.
Accepted 2025-12-16 00:00:00 ET · period of report 2025-12-12 · accession 0001193125-25-320941 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2025-12-16 | 2025-12-12 | TYRA | Bensen Daniel | Chief Discovery Off | S - Sale | $22.64 | -8,000 | 163.0K | -5% | -$181.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-12 | S | D | 8,000 | $22.64 | 162,981 | D | — | — | (F2) Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $22.06 to $23.03. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request. |